Development of a Network-Based Signal Detection Tool: The COVID-19 Adversome in the FDA Adverse Event Reporting System

Introduction: The analysis of pharmacovigilance databases is crucial for the safety profiling of new and repurposed drugs, especially in the COVID-19 era. Traditional pharmacovigilance analyses–based on disproportionality approaches–cannot usually account for the complexity of spontaneous reports of...

Descripción completa

Detalles Bibliográficos
Autores principales: Fusaroli, Michele, Raschi, Emanuel, Gatti, Milo, De Ponti, Fabrizio, Poluzzi, Elisabetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694570/
https://www.ncbi.nlm.nih.gov/pubmed/34955821
http://dx.doi.org/10.3389/fphar.2021.740707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694570/
https://www.ncbi.nlm.nih.gov/pubmed/34955821
http://dx.doi.org/10.3389/fphar.2021.740707

Ejemplares similares